A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

Clinical trial NCT05451849 · TERMINATED

Trial details

NCT number: NCT05451849
Sponsor: TCR2 Therapeutics
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mesothelioma Mesotheliomas Pleural Mesothelioma, Malignant Mesothelioma Peritoneum Ovarian Cancer Ovarian Serous Adenocarcinoma Pancreatic Cancer Pancreatic Adenocarcinoma Colorectal Cancer Triple Negative Breast Cancer TNBC - Triple-Negative Breast Cancer Ovarian Adenocarcinoma

Start date: 2022-06-21
Primary completion: 2025-08-30
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.